JPRN-UMIN000020331
Completed
N/A
The potential effect of Dapagliflozin on diabetic macular edema - The potential effect of Dapagliflozin on diabetic macular edema
Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism0 sites45 target enrollmentDecember 24, 2015
Conditionsdiabetic macular edema, diabetes
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- diabetic macular edema, diabetes
- Sponsor
- Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Refusal or lack of capacity to give informed consent The contraindications use of Dapagliflozin History of SGLT2i eGFR \<45mL/min/1\.73m2 Anti GAD antibody positive Pregnant or current Brest feeding Recent history of cardiovascular events AST and/or ALT \> 3x upper limit of normal Total bilirubin \> 3\.0 mg/d
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 4
Dapagliflozin in Acute Heart failureIRCT20220529055013N1Public Sector medical University160
Not Yet Recruiting
N/A
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
Completed
N/A
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50
Not Yet Recruiting
Phase 4
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100
Active, Not Recruiting
Phase 1
Dapaglifozin use in patients with heart failure during acute myocardial infarctioEUCTR2021-002813-33-ITAZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA140